In the present study, we tested the hypothesis that platelet-derived growth factor receptor-alpha (PDGFRα) is a key molecular target for DHA as a selective anti-PDGFRα-positive ovarian cancer agent. Here, PDGFRA is linked to ovarian carcinoma.